Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Prostate Cancer

Free Subscription Articles published in Urology Retrieve available abstracts of 190 articles: HTML format

Single Articles

October 2026
1. WYNNE M, Fu H, Millan B
   Editorial Comment on "Detection of Clinically Significant Prostate Cancer on Systematic Biopsy in Patients with a PI-RADS 3-5 Lesion on MRI: Results from a Large Institutional Series".
   Urology. 2026 Oct 2:S0090-4295(26)00636-9. doi: 10.1016/j.urology.2026.
   PubMed    
   
   
   September 2026
2. BRITTON CJ, Assani K, White RE, Robinson H, et al
   Detection of Clinically-Significant Prostate Cancer on Systematic Biopsy in Patients with a PI-RADS 3-5 Lesion on MRI: Results from a Large Institutional Series.
   Urology. 2026 Sep 17:S0090-4295(26)00581-9. doi: 10.1016/j.urology.2026.
   PubMed     Abstract available
   
   
   
3. FLETCHER SA, Cotta BH, Vertosick EA, Liso N, et al
   Concordance Between MRI Findings and Targeted Biopsy for Local Recurrence Following Radical Prostatectomy.
   Urology. 2026;215:115-118.
   PubMed     Abstract available
   
   
   
4. WHITLOCK NC, Silver R, Trostel SY, Li C, et al
   Integrative Genomic Profiling of Newly Diagnosed Prostate Cancers Progressing on Surveillance.
   Urology. 2026;215:89-96.
   PubMed     Abstract available
   
   
   
5. LUCA D, Pensa JW, Rehmani AK, Geoghegan R, et al
   A Histopathologic Assessment of Prostate Ductal Anatomy in Relation to Micro-ultrasound.
   Urology. 2026;215:6-10.
   PubMed     Abstract available
   
   
   August 2026
6. TILL C, Tangen CM, Goodman P, Unger JM, et al
   No Evidence of Post-Finasteride Syndrome in 267,983 person-years follow-up in the Prostate Cancer Prevention Trial.
   Urology. 2026 Aug 21:S0090-4295(26)00529-7. doi: 10.1016/j.urology.2026.
   PubMed     Abstract available
   
   
   
7. KIM IE JR, Hartman R, Gandhi K, Nikita N, et al
   Mortality in Medicare-aged Men with Metastatic Prostate Cancer After the Introduction of Androgen Receptor Pathway Inhibitors: A Population-Based Study.
   Urology. 2026 Aug 4:S0090-4295(26)00491-7. doi: 10.1016/j.urology.2026.
   PubMed     Abstract available
   
   
   
8. CHE R, Milton A, Simpson R, Akbar Z, et al
   Sexual Orientation and Healthcare Access Factors Associated With Prostate-specific Antigen Screening in the United States.
   Urology. 2026;214:80-86.
   PubMed     Abstract available
   
   
   July 2026
9. BLANCAFLOR A, Ochsner A, Glebocki R, Westrick L, et al
   Immediate Release of Prostate Biopsy Results: Perspectives From Patients and Providers.
   Urology. 2026;213:96-100.
   PubMed     Abstract available
   
   
   June 2026
10. MASON JB, Tallman JE
    Editorial Comment on: "Frailty and Quality of Life in Low-Income, Uninsured Men with Prostate Cancer".
    Urology. 2026 Jun 8:S0090-4295(26)00365-1. doi: 10.1016/j.urology.2026.
    PubMed    
    
    
    
11. LEPOR H, Fiske J, Tafa M, Pirraglia E, et al
    Focal Cryo-ablation for Treatment of Intermediate Favorable Risk (Grade Group 2) Prostate Cancer.
    Urology. 2026 Jun 1:S0090-4295(26)00343-2. doi: 10.1016/j.urology.2026.
    PubMed     Abstract available
    
    
    
12. OZTURK E, Bolat A, Canbolat MZ, Cayirli A, et al
    Metronome Rhythm Based Auditory Stimulation Modulates Pain and Anxiety During Transperineal Prostate Biopsy: A Prospective Clinical Study.
    Urology. 2026;212:60-65.
    PubMed     Abstract available
    
    
    May 2026
13. VARGHESE E, Chen J, Kwan L, Litwin MS, et al
    Frailty and Quality of Life in Low-Income, Uninsured Men with Prostate Cancer.
    Urology. 2026 May 21:S0090-4295(26)00319-5. doi: 10.1016/j.urology.2026.
    PubMed     Abstract available
    
    
    
14. MADHAVARAM A, Whitman J, McCracken P, Sanborn CJ, et al
    Patient Preferences for Treatment of Intermediate-Risk Prostate Cancer: A Discrete Choice Experiment.
    Urology. 2026 May 18:S0090-4295(26)00209-8. doi: 10.1016/j.urology.2026.
    PubMed     Abstract available
    
    
    April 2026
15. KIM IE JR, Chung BI, Puri D, Soerensen SJC, et al
    Associations Between Medicaid Insurance, Facility Medicaid Share, and Guideline-Concordant Prostate Cancer Care.
    Urology. 2026 Apr 28:S0090-4295(26)00291-8. doi: 10.1016/j.urology.2026.
    PubMed     Abstract available
    
    
    
16. ADLER R, Kozlov M, Viola J, Ingram J, et al
    The Risk of Benign Prostatic Hyperplasia and Prostate Cancer With Long-Term, Low Dose Finasteride Use in Adult Men with Nonscarring Alopecia: A Propensity-Matched Observational Study.
    Urology. 2026 Apr 23:S0090-4295(26)00254-2. doi: 10.1016/j.urology.2026.
    PubMed     Abstract available
    
    
    
17. MANIVASAGAM SS
    Editorial Comment on "Primary Care Physician Led Population Based Screening Program for Prostate Cancer: Bridging a Urologic Gap in Access to Care".
    Urology. 2026 Apr 14:S0090-4295(26)00247-5. doi: 10.1016/j.urology.2026.
    PubMed    
    
    
    
18. MEHR JP, Talwar R
    Editorial Comment on "Patient preferences for treatment of intermediate-risk prostate cancer: A discrete choice experiment".
    Urology. 2026 Apr 14:S0090-4295(26)00248-7. doi: 10.1016/j.urology.2026.
    PubMed    
    
    
    
19. NAELITZ BD, Siva J, Vallabhaneni S, Momtazi-Mar L, et al
    Varicocele and Untreated Hypogonadism Synergistically Increase Prostate Cancer Risk via Testosterone Shunt Physiology and can be Ameliorated with Testosterone Therapy.
    Urology. 2026 Apr 14:S0090-4295(26)00243-8. doi: 10.1016/j.urology.2026.
    PubMed     Abstract available
    
    
    
20. FINK KE, Liu Y, Wiarda G, Gowda A, et al
    Comparative Performance of Prostate Cancer Risk Prediction Tools in Gay, Bisexual, and Other Men Who Have Sex with Men Versus Heterosexual Men.
    Urology. 2026 Apr 13:S0090-4295(26)00236-0. doi: 10.1016/j.urology.2026.
    PubMed     Abstract available
    
    
    
21. ASHBROOK C, Troia TC, Woldu SL, Argenbright K, et al
    Primary Care Physician-Led Population-Based Screening Program for Prostate Cancer: Bridging a Urologic Gap in Access to Care.
    Urology. 2026 Apr 3:S0090-4295(26)00230-X. doi: 10.1016/j.urology.2026.
    PubMed     Abstract available
    
    
    March 2026
22. BRADLEY MASON J, Tallman J
    Editorial Comment on "Patient-Reported Psychological and Prostate Cancer-Specific Functional Outcomes Among Men With Low-Risk Prostate Cancer Two Years After Diagnosis: The PREPARE Prospective Cohort Study".
    Urology. 2026 Mar 24:S0090-4295(26)00211-6. doi: 10.1016/j.urology.2026.
    PubMed    
    
    
    
23. SHORE N
    Editorial Comment on "Homologous recombination repair mutations, next-generation sequencing testing, and treatment progression by race among patients with metastatic castration-sensitive prostate cancer".
    Urology. 2026 Mar 11:S0090-4295(26)00167-6. doi: 10.1016/j.urology.2026.
    PubMed    
    
    
    
24. DAVIS KM, Luta G, Hoffman RM, Lobo T, et al
    Patient-reported psychological and prostate cancer-specific functional outcomes among men with low-risk prostate cancer two years after diagnosis: The PREPARE prospective cohort study.
    Urology. 2026 Mar 10:S0090-4295(26)00154-8. doi: 10.1016/j.urology.2026.
    PubMed     Abstract available
    
    
    
25. YILDIZ AK, Gultekin H, Kacan T, Demir DO, et al
    Evaluation of Multifocal Positive Surgical Margin Predictors and Mapping of Positive Surgical Margin Locations in Robot-assisted Radical Prostatectomy.
    Urology. 2026;209:66-71.
    PubMed     Abstract available
    
    
    February 2026
26. COCKRUM J, Monda S
    Editorial Comment on "Homologous Recombination Repair Mutations, Next-Generation Sequencing Testing, and Treatment Progression by Race Among Patients with Metastatic Castration-Sensitive Prostate Cancer".
    Urology. 2026 Feb 13:S0090-4295(26)00102-0. doi: 10.1016/j.urology.2026.
    PubMed    
    
    
    
27. PATNAIK S, Maganty A
    Editorial Comment on "Sociodemographic Factors Associated with Tissue-Based Genomic Testing for Prostate Cancer".
    Urology. 2026 Feb 3:S0090-4295(26)00085-3. doi: 10.1016/j.urology.2026.
    PubMed    
    
    
    
28. HOLZBEIERLEIN H, Kundu N, Handa N, Jang JW, et al
    Performance of the Prostate Health Index Test in Men With Prostate Specific Antigen Levels Between 10 and 20 ng/mL.
    Urology. 2026;208:112-116.
    PubMed     Abstract available
    
    
    
29. XIAO B, Qian Z, Look-Why SL, Piccolini A, et al
    Prostate Biopsy and Malpractice: Analysis of a National Legal Database from 1995 to 2025.
    Urology. 2026;208:117-123.
    PubMed     Abstract available
    
    
    
30. LENG L, Maremanda A, Li KD, Pace WA, et al
    Genitourinary Radiation Injury: A Mixed-methods Study Exploring Patient-reported Outcomes and Impact on Quality of Life.
    Urology. 2026;208:59-66.
    PubMed     Abstract available
    
    
    
31. SONG JJ, Lee SZ, Zhou MT, Jones JM, et al
    Smoking and Surgical Complications Following Robotic-assisted Laparoscopic Radical Prostatectomy: A NSQIP Analysis.
    Urology. 2026;208:106-111.
    PubMed     Abstract available
    
    
    
32. REZAEE ME, Meeks W, Galen E, Helsel A, et al
    Examining Variation in Prostate Biopsy Practices in the United States: An Analysis of American Urological Association Census Data.
    Urology. 2026;208:9-13.
    PubMed     Abstract available
    
    
    
33. SCHMEUSSER BN, Zappia JL, Edwards KR, Adaniya KH, et al
    Reliability of Prostate Imaging-reporting and Data System Scoring Following Holmium Laser Enucleation of Prostate.
    Urology. 2026;208:91-95.
    PubMed     Abstract available
    
    
    January 2026
34. HANSEN SC, Schlaepfer CH, Shane DM, Erickson BA, et al
    Measuring the Impact of Common Prostate Cancer Survivorship Conditions with Health Utilities.
    Urology. 2026 Jan 29:S0090-4295(26)00062-2. doi: 10.1016/j.urology.2026.
    PubMed     Abstract available
    
    
    
35. SHACHAR E, Connor SE, Chen J, Kwan L, et al
    Authors' Reply to Editorial Comments on, "Fear of Cancer Recurrence among Uninsured and Underrepresented Men with Prostate Cancer".
    Urology. 2026 Jan 29:S0090-4295(26)00071-3. doi: 10.1016/j.urology.2026.
    PubMed    
    
    
    
36. BILEN MA, Shore N, Burbage S, Rossi C, et al
    Homologous recombination repair mutations, next-generation sequencing testing, and treatment progression by race among patients with metastatic castration-sensitive prostate cancer.
    Urology. 2026 Jan 29:S0090-4295(26)00060-9. doi: 10.1016/j.urology.2026.
    PubMed     Abstract available
    
    
    
37. ASHOURI R, Reynolds PS, Rajavel S, Hanchate K, et al
    Development of a Prognostic Prediction Model for Clinically Significant Prostate Cancer Based on Lesion Zone and Apparent Diffusion Coefficient Value Quantification.
    Urology. 2026 Jan 28:S0090-4295(26)00061-0. doi: 10.1016/j.urology.2026.
    PubMed     Abstract available
    
    
    
38. MONTGOMERY J
    Editorial Comment on "Fear of Cancer Recurrence among Uninsured and Underrepresented Men with Prostate Cancer".
    Urology. 2026 Jan 21:S0090-4295(26)00037-3. doi: 10.1016/j.urology.2026.
    PubMed    
    
    
    
39. SOHONI N, Sohoni NS, Sutherland RA, Sundaresan VM, et al
    Automated Classification of Adverse Events After Hydrogel Perirectal Spacer Insertion for Prostate Cancer Using Large Language Models.
    Urology. 2026 Jan 19:S0090-4295(26)00017-8. doi: 10.1016/j.urology.2026.
    PubMed     Abstract available
    
    
    
40. SHACHAR E, Connor SE, Chen J, Kwan L, et al
    Fear of Cancer Recurrence among Uninsured and Underrepresented Men with Prostate Cancer.
    Urology. 2026 Jan 12:S0090-4295(26)00010-5. doi: 10.1016/j.urology.2025.
    PubMed     Abstract available
    
    
    
41. PRUITT D, Von P, Gardner T, Paul E, et al
    Assessing Clinical Utility in Randomized Trials of Radical Prostatectomy for Urologic Oncology: An Original Article of Studies Published Between 2020 and 2024.
    Urology. 2026;207:261-266.
    PubMed     Abstract available
    
    
    
42. WESTERHOUT SF, Rynja SP, van Steenbergen JPZ, Mertens LS, et al
    Antibiotic Prophylaxis Is Not Required Before MRI-Guided Transperineal Prostate Biopsy.
    Urology. 2026;207:166-171.
    PubMed     Abstract available
    
    
    December 2025
43. DEMASI M, Evans A, Syphan T, Murphy J, et al
    Divergent Trends in PSA Screening Prior to Testosterone Therapy in Younger vs. Older Men Amidst Shifting Guidelines.
    Urology. 2025 Dec 22:S0090-4295(25)01399-8. doi: 10.1016/j.urology.2025.
    PubMed     Abstract available
    
    
    
44. DIAZ GM, Sivanesan N, Strachan S, Sohoni N, et al
    Sociodemographic Factors Associated with Tissue-Based Genomic Testing for Prostate Cancer.
    Urology. 2025 Dec 16:S0090-4295(25)01357-3. doi: 10.1016/j.urology.2025.
    PubMed     Abstract available
    
    
    
45. WOODLE T, Hebert K, Kurtzman JT, Horns JJ, et al
    Defining Long-Term Prostate Cancer Treatment Patterns and Adverse Urologic Events: A Methodological Framework and Patient Outcomes Using the Utah Population Database.
    Urology. 2025 Dec 4:S0090-4295(25)01352-4. doi: 10.1016/j.urology.2025.
    PubMed     Abstract available
    
    
    
46. AHMAD Z
    Integration of Wearable Digital Urinary Sensors and Patient-reported Outcomes to Monitor Post-prostatectomy Incontinence: A Prospective Pilot Study.
    Urology. 2025;206:25-30.
    PubMed     Abstract available
    
    
    November 2025
47. SMANI S, Wang R, Zhou X, Sprenkle PC, et al
    Area-Level Social Deprivation and Use of Prostate MRI Before Prostate Biopsy Among Commercial Insurance Beneficiaries.
    Urology. 2025;205:145-151.
    PubMed     Abstract available
    
    
    
48. ARENAS-GALLO C, Goldman M, Millot JC, McCann J, et al
    Increasing Utilization of Sedation for Prostate Biopsies: National Trends, Predictors, and Patient Cost.
    Urology. 2025;205:112-118.
    PubMed     Abstract available
    
    
    
49. CAHILL EM, de Oca EMM, Flores JM, Bennett NE, et al
    Knowledge and Attitudes Towards Fertility Preservation in Patients Undergoing Radical Prostatectomy.
    Urology. 2025;205:75-79.
    PubMed     Abstract available
    
    
    October 2025
50. SLOTA J, Lee Z
    Reply to Editorial Comment on "Economic Burden of Urinary Incontinence in Men with Prostate Cancer: Results from the Medical Expenditure Panel Survey (2016-2021)".
    Urology. 2025 Oct 23:S0090-4295(25)01031-3. doi: 10.1016/j.urology.2025.
    PubMed    
    
    
    
51. KHAN S, Harper A, Yang L, Sutcliffe S, et al
    Reply to Letter to the Editor on "Impact of Age, Marital Status, Smoking, and Alcohol Consumption on Urinary and Sexual Function in Prostate Cancer Patients Treated With Radical Prostatectomy: A Prospective Cohort Study".
    Urology. 2025 Oct 16:S0090-4295(25)01008-8. doi: 10.1016/j.urology.2025.
    PubMed    
    
    
    
52. GILLIS CJ
    Editorial Comment on "Patient-Centered Priorities in Prostate Cancer Survivorship Care".
    Urology. 2025 Oct 15:S0090-4295(25)01003-9. doi: 10.1016/j.urology.2025.
    PubMed    
    
    
    
53. SORENSEN KH, Levinsen AKG, Kjaer TK, Borre M, et al
    Associations between stress urinary incontinence and self-reported functioning and urinary symptoms among survivors of prostate cancer treated with radical prostatectomy.
    Urology. 2025 Oct 15:S0090-4295(25)01011-8. doi: 10.1016/j.urology.2025.
    PubMed     Abstract available
    
    
    
54. ORCUTT DJ, Chisholm L, Winkler E, Kaufman MR, et al
    Patient-Centered Priorities in Prostate Cancer Survivorship Care.
    Urology. 2025 Oct 2:S0090-4295(25)00940-9. doi: 10.1016/j.urology.2025.
    PubMed     Abstract available
    
    
    
55. HANDA N, Kaul H, Neill C, Proudfoot JA, et al
    A novel application of Decipher testing in HoLEP specimens for risk stratification of incidentally detected prostate cancer.
    Urology. 2025 Oct 1:S0090-4295(25)00937-9. doi: 10.1016/j.urology.2025.
    PubMed     Abstract available
    
    
    
56. PICCOLINI A, Qian Z, Korn SM, Dagnino F, et al
    Exploring the Impact of Mental Health on PSA Screening: Insights From a Population-Based Survey.
    Urology. 2025;204:112-120.
    PubMed     Abstract available
    
    
    September 2025
57. VAFAEI E
    Editorial Comment on "Economic Burden of Urinary Incontinence in Men with Prostate Cancer: Results from the Medical Expenditure Panel Survey (2016-2021)".
    Urology. 2025 Sep 26:S0090-4295(25)00911-2. doi: 10.1016/j.urology.2025.
    PubMed    
    
    
    
58. MAY M, Wolff I, Burger M, Brookman-May S, et al
    Letter to the Editor on "Impact of Age, Marital Status, Smoking, and Alcohol Consumption on Urinary and Sexual Function in Prostate Cancer Patients Treated With Radical Prostatectomy: A Prospective Cohort Study".
    Urology. 2025 Sep 23:S0090-4295(25)00900-8. doi: 10.1016/j.urology.2025.
    PubMed    
    
    
    
59. SLOTA J, Naser-Tavakolian A, Ji E, Driscoll C, et al
    Economic Burden of Urinary Incontinence in Men with Prostate Cancer: Results from the Medical Expenditure Panel Survey (2016-2021).
    Urology. 2025 Sep 12:S0090-4295(25)00884-2. doi: 10.1016/j.urology.2025.
    PubMed     Abstract available
    
    
    
60. MARTIN C, Maoate K, Hooshyari A, Ordones FV, et al
    Transitioning to Office-based Transperineal Prostate Biopsy-A Case Study From a Regional New Zealand Hospital in Economic and Environmental Sustainability.
    Urology. 2025;203:53-59.
    PubMed     Abstract available
    
    
    August 2025
61. GARNICK MB, Kent MA
    Editorial Comment on "Prostate Specific Antigen Testing and Prostate Cancer Diagnosis Rates Among Transgender and Nonbinary Patients: Retrospective Review of a Single-Institution Experience".
    Urology. 2025 Aug 22:S0090-4295(25)00804-0. doi: 10.1016/j.urology.2025.
    PubMed    
    
    
    
62. ZHU A, Tin AL, Vickers AJ, Kowalczyk K, et al
    Effect of Age on Robotic-Assisted Radical Prostatectomy Outcomes: A Multi-center Analysis.
    Urology. 2025;202:78-84.
    PubMed     Abstract available
    
    
    
63. KARWACKI J, Wojdylo L, Klasen K, Dlubak A, et al
    Reply to Letter to the Editor on "Revisiting the Role of Lymphovascular Invasion in Prostate Cancer: A Narrative Review".
    Urology. 2025 Aug 1:S0090-4295(25)00750-2. doi: 10.1016/j.urology.2025.
    PubMed    
    
    
    July 2025
64. MICHAEL JA, Greenberg DR, Ascha M, Gonzales-Alabastro CD, et al
    Prostate Specific Antigen Testing and Prostate Cancer Diagnosis Rates Among Transgender and Nonbinary Patients: Retrospective Review of a Single-Institution Experience.
    Urology. 2025 Jul 31:S0090-4295(25)00735-6. doi: 10.1016/j.urology.2025.
    PubMed     Abstract available
    
    
    
65. ZHANG C, Harper A, Imm KR, Grubb Iii RL, et al
    Impact of age, marital status, smoking, and alcohol consumption on urinary and sexual function in prostate cancer patients treated with radical prostatectomy: a prospective cohort study.
    Urology. 2025 Jul 25:S0090-4295(25)00729-0. doi: 10.1016/j.urology.2025.
    PubMed     Abstract available
    
    
    
66. MAY M, Wolff I, Burger M, Brookman-May S, et al
    Letter to the Editor on "Revisiting the Role of Lymphovascular Invasion in Prostate Cancer: A Narrative Review".
    Urology. 2025 Jul 18:S0090-4295(25)00701-0. doi: 10.1016/j.urology.2025.
    PubMed    
    
    
    
67. KARS M, Cimsit C, Genc YE, Bicakci E, et al
    Effectiveness of Mapping for Cognitive Prostate Biopsy: A Prospective, Randomized Study.
    Urology. 2025;201:84-90.
    PubMed     Abstract available
    
    
    
68. KARWACKI J, Wojdylo L, Klasen K, Dlubak A, et al
    Revisiting the role of lymphovascular invasion in prostate cancer: a narrative review.
    Urology. 2025 Jul 1:S0090-4295(25)00642-9. doi: 10.1016/j.urology.2025.
    PubMed     Abstract available
    
    
    
69. MILLOT JC, Balasubramanian A, Chew L, Wald G, et al
    Utilization, Acute Complications, and Delays in Treatment Associated with Rectal Spacers for Prostate Cancer Radiotherapy.
    Urology. 2025 Jul 1:S0090-4295(25)00647-8. doi: 10.1016/j.urology.2025.
    PubMed     Abstract available
    
    
    May 2025
70. FRIEDRICH NA, Kokorowski P, Luu M, Chaplin A, et al
    Topic Mapping to Inform Content to Discuss in Shared Decision-Making for Prostate Cancer.
    Urology. 2025 May 28:S0090-4295(25)00511-4. doi: 10.1016/j.urology.2025.
    PubMed     Abstract available
    
    
    
71. FANG A, Frigo DE, Hahn A, Razouki Z, et al
    GLP-1 Agonist Use Among Men with Localized Prostate Cancer: A Narrative Review and Rationale for Prospective Clinical Trials.
    Urology. 2025 May 8:S0090-4295(25)00426-1. doi: 10.1016/j.urology.2025.
    PubMed     Abstract available
    
    
    
72. CIANFLONE F, Maris B, Bertolo R, Veccia A, et al
    Development of Artificial Intelligence-based Real-time Automatic Fusion of Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasonography of the Prostate.
    Urology. 2025;199:27-34.
    PubMed     Abstract available
    
    
    April 2025
73. ASSANI KD, Scarpato KR
    Editorial Comment on Low baseline IsoPSA Index is associated with a Prolonged Low Risk of Clinically Significant Prostate Cancer Diagnosis in Men with an Elevated PSA.
    Urology. 2025 Apr 29:S0090-4295(25)00402-9. doi: 10.1016/j.urology.2025.
    PubMed    
    
    
    
74. BULLER D, Lin F, Wagner J, Antony M, et al
    Transperineal Magnetic Resonance Imaging-Fusion Targeted Prostate Biopsy Utilizing the PrecisionPoint Transperineal Access System vs a Grid Template: An Assessment of Outcomes.
    Urology. 2025;198:87-94.
    PubMed     Abstract available
    
    
    
75. MEI H, Wang Z, Zheng Q, Jiao P, et al
    Deep Learning for Predicting Difficulty in Radical Prostatectomy: A Novel Evaluation Scheme.
    Urology. 2025;198:1-7.
    PubMed     Abstract available
    
    
    March 2025
76. MEHTA R, Kumar S, Sah R
    Comment on "Should Military Veterans Be Classified as High Risk for Prostate Cancer Screening? A Systematic Review and Meta-analysis".
    Urology. 2025 Mar 21:S0090-4295(25)00285-7. doi: 10.1016/j.urology.2025.
    PubMed    
    
    
    
77. SHAH YB, Golla V, Nielsen ME, Talwar R, et al
    Payment Bundles for Prostatectomy: A New Way to Improve Value for Prostate Cancer Care.
    Urology. 2025 Mar 21:S0090-4295(25)00286-9. doi: 10.1016/j.urology.2025.
    PubMed     Abstract available
    
    
    
78. BOCHNER E, Johnson B, Franzen B, Hertz A, et al
    Artificial Urinary Sphincter Placement Before or After Radiation Therapy: Does Timing of Radiation Impact Surgical Complications and Continence?
    Urology. 2025;197:185-189.
    PubMed     Abstract available
    
    
    
79. BRODSKY CN, Daignault-Newton S, Davenport MS, Marchetti KA, et al
    How Many Cores Should Be Collected per Region of Interest in Fusion Targeted Prostate Biopsy? A Retrospective Single Institution Statistical Simulation.
    Urology. 2025;197:133-140.
    PubMed     Abstract available
    
    
    
80. PICKERSGILL NA, Alkazemi MH, Ostergar A, Joseph K, et al
    Correlation of Prostate High-Resolution Microultrasound With Multiparametric Magnetic Resonance Imaging.
    Urology. 2025;197:33-39.
    PubMed     Abstract available
    
    
    February 2025
81. DE BARROS HA, Downes MR, Droghetti M, Bekers EM, et al
    Prognostic Value of Cribriform and Intraductal Carcinoma in Grade Group 2 Prostate Cancer with and without Synchronous Nodal Metastases at Radical Prostatectomy: Results from a Case-Control Matched, Multicenter Study.
    Urology. 2025 Feb 6:S0090-4295(25)00109-8. doi: 10.1016/j.urology.2025.
    PubMed     Abstract available
    
    
    
82. SHORE N, Armstrong AJ, Barata P, Byrne L, et al
    Implementing and Optimizing Universal Germline Genetic Testing for Patients with Prostate Cancer in Clinical Practice Consider.
    Urology. 2025 Feb 3:S0090-4295(25)00114-1. doi: 10.1016/j.urology.2025.
    PubMed     Abstract available
    
    
    
83. OZTURK E, Ozden E, Isikdogan M, Dagli I, et al
    The Effect of Listening to Music on Pain and Anxiety Scores During Office Based Transperineal Prostate Biopsy: A Prospective Study.
    Urology. 2025;196:254-259.
    PubMed     Abstract available
    
    
    
84. DAGNINO F, Labban M, Berk B, Qian Z, et al
    Trends and Safety of Same-day Discharge for Robot-assisted Laparoscopic Prostatectomy: A Comparison Between the Pre-pandemic and Pandemic Periods From the National Cancer Database.
    Urology. 2025;196:165-173.
    PubMed     Abstract available
    
    
    January 2025
85. RASTER G, Helfand BT
    Aquablation Safety and Outcomes Among Men with Prostate Cancer.
    Urology. 2025 Jan 30:S0090-4295(25)00107-4. doi: 10.1016/j.urology.2025.
    PubMed    
    
    
    
86. ABDALLAH N, Campbell RA, Benidir T, Wood A, et al
    Low baseline IsoPSA Index is associated with a Prolonged Low Risk of Clinically Significant Prostate Cancer Diagnosis in Men with an Elevated PSA.
    Urology. 2025 Jan 15:S0090-4295(25)00031-7. doi: 10.1016/j.urology.2025.
    PubMed     Abstract available
    
    
    
87. TEOH JYC, Yuen SKK, Lau BSY, Lai FPT, et al
    Robotic Waterjet Resection for Men with Prostate Cancer Suffering from Lower Urinary Tract Symptoms.
    Urology. 2025 Jan 14:S0090-4295(25)00034-2. doi: 10.1016/j.urology.2025.
    PubMed     Abstract available
    
    
    
88. AGRAWAL-PATEL S
    Editorial Comment on "Prostate Cancer Screening and Diagnoses in the Transfeminine Population.
    Urology. 2025 Jan 3:S0090-4295(24)01235-4. doi: 10.1016/j.urology.2024.
    PubMed    
    
    
    December 2024
89. LEAPMAN MS
    Market Forces in Prostate Cancer Care.
    Urology. 2024 Dec 16:S0090-4295(24)01140-3. doi: 10.1016/j.urology.2024.
    PubMed    
    
    
    
90. CHECCUCCI E, Bauckneht M, Gandaglia G, Porpiglia F, et al
    REPLY TO "PSMA PET-targeted Biopsy for Prostate Cancer Diagnosis: Initial Experience from a Multicenter Cohort".
    Urology. 2024 Dec 13:S0090-4295(24)01138-5. doi: 10.1016/j.urology.2024.
    PubMed    
    
    
    
91. BACA AL, Chung C, Kanmaniraja D, Duong TQ, et al
    A Call for the Inclusion and Reporting of Race and Ethnicity Demographics in Artificial Intelligence Research for Prostate Cancer Detection on Magnetic Resonance Imaging.
    Urology. 2024 Dec 4:S0090-4295(24)01097-5. doi: 10.1016/j.urology.2024.
    PubMed    
    
    
    
92. SAFFATI G, Kronstedt S, Jones JA
    REPLY TO "Editorial Comment on "Should Military Veterans Be Classified as High Risk for Prostate Cancer Screening? A Systematic Review and Meta-analysis".
    Urology. 2024 Dec 2:S0090-4295(24)01122-1. doi: 10.1016/j.urology.2024.
    PubMed    
    
    
    
93. CHAVARRIAGA J, Penn LZ, Khurram N, Lajkosz K, et al
    Statin Concentration in Prostatic Tissue is Subtype- and Dose-dependent.
    Urology. 2024;194:172-179.
    PubMed     Abstract available
    
    
    
94. QIAN Z, Chen YJ, Moman P, Labban M, et al
    Identifying Barriers to Timely Follow-up After Elevated PSA Screening: A Retrospective Analysis of a Large Healthcare System.
    Urology. 2024;194:165-171.
    PubMed     Abstract available
    
    
    
95. FLORES JM, Thorogood S, Jenkins LC, Miyagi H, et al
    Does Diabetes Have a Negative Impact on Erectile Function Recovery After Radical Prostatectomy?
    Urology. 2024;194:327-332.
    PubMed     Abstract available
    
    
    November 2024
96. HAYWOOD SC
    Editorial Comment on "PSMA PET-targeted Biopsy for Prostate Cancer Diagnosis: Initial Experience from a Multicenter Cohort".
    Urology. 2024 Nov 23:S0090-4295(24)01090-2. doi: 10.1016/j.urology.2024.
    PubMed    
    
    
    
97. MAGANTY A, Kaufman SR, Oerline MK, Faraj K, et al
    Commercial prices and care for Medicare beneficiaries with prostate cancer.
    Urology. 2024 Nov 22:S0090-4295(24)01055-0. doi: 10.1016/j.urology.2024.
    PubMed     Abstract available
    
    
    
98. STEPHENS A, Morrison C, Lutchka J, Richard C, et al
    Prostate Cancer Screening and Diagnoses in the Transfeminine Population.
    Urology. 2024 Nov 21:S0090-4295(24)01083-5. doi: 10.1016/j.urology.2024.
    PubMed     Abstract available
    
    
    
99. TAY KJ
    Editorial Comment on "5-year Oncologic Outcomes Following Primary Partial Gland Cryo-Ablation (PPGCA) Prospective Cohort Study of Men with Intermediate-Risk Prostate Cancer".
    Urology. 2024 Nov 19:S0090-4295(24)01066-5. doi: 10.1016/j.urology.2024.
    PubMed    
    
    
    
100. PERRY AG, Qualkenbush E, Pak RW, Pathak RA, et al
     Reply to "Virtual reality as an adjunct to traditional patient counseling in patients with newly-diagnosed localized prostate cancer".
     Urology. 2024 Nov 12:S0090-4295(24)01058-6. doi: 10.1016/j.urology.2024.
     PubMed    
     
     
     
101. ORDONES FV, Kawano PR, Vermeulen L, Hooshyari A, et al
     A Novel Machine Learning-Based Predictive Model of Clinically Significant Prostate Cancer and Online Risk Calculator.
     Urology. 2024 Nov 11:S0090-4295(24)01057-4. doi: 10.1016/j.urology.2024.
     PubMed     Abstract available
     
     
     
102. DAVID CRAWFORD E, Crosby M
     Editorial Comment on "Should Military Veterans Be Classified as High Risk for Prostate Cancer Screening? A Systematic Review and Meta-analysis".
     Urology. 2024 Nov 5:S0090-4295(24)00978-6. doi: 10.1016/j.urology.2024.
     PubMed    
     
     
     
103. SHORE N, Brown G, Lowentritt B, O'Donnell L, et al
     Evaluating the Importance of Practice-Level Factors on Adherence to Prostate Cancer Treatment Guidelines in Urology.
     Urology. 2024 Nov 1:S0090-4295(24)00950-6. doi: 10.1016/j.urology.2024.
     PubMed     Abstract available
     
     
     
104. MALSHY K, Marthi S, Ortiz R, Nicaise E, et al
     Timing Considerations for Artificial Urinary Sphincter Implantation Postpelvic Radiotherapy.
     Urology. 2024;193:214-219.
     PubMed     Abstract available
     
     
     
105. ATCHIA K, Turcotte B, Cazes E, Singbo N, et al
     Effect of a Modified Technique of Posterior Reconstruction by Iliopectineal Ligament Suspension During Robot-assisted Laparoscopic Radical Prostatectomy on Early Continence: A Randomised Controlled Trial.
     Urology. 2024;193:116-122.
     PubMed     Abstract available
     
     
     
106. RABIL MJ, Jalfon M, Heckscher D, Song Z, et al
     Association of Crowd-Sourced Assessment of Technical Skills and Outcomes of Robotic-assisted Radical Prostatectomy.
     Urology. 2024;193:87-94.
     PubMed     Abstract available
     
     
     
107. SAWHNEY V, Huang R, Huang WC, Lepor H, et al
     Predictors of Contralateral Disease in Men With Unilateral Lesions on Multiparametric Magnetic Resonance Imaging.
     Urology. 2024;193:147-152.
     PubMed     Abstract available
     
     
     October 2024
108. RIVERA LOPEZ CA, Cheaib J, Singla N
     Editorial Comment on "Virtual reality as an adjunct to traditional patient counselling in patients with newly-diagnosed localized prostate cancer".
     Urology. 2024 Oct 23:S0090-4295(24)00929-4. doi: 10.1016/j.urology.2024.
     PubMed    
     
     
     
109. LEPOR H, Rapoport E, Tafa M, Gogaj R, et al
     5-year Oncologic Outcomes Following Primary Partial Gland Cryo-Ablation (PPGCA) Prospective Cohort Study of Men with Intermediate-Risk Prostate Cancer.
     Urology. 2024 Oct 22:S0090-4295(24)00925-7. doi: 10.1016/j.urology.2024.
     PubMed     Abstract available
     
     
     
110. RATHI N, Blake Z, Hyman J, Nemirovsky DR, et al
     Castration Levels of Testosterone Results in Atrophy of Androgen-Sensitive Perineal Muscles: A Potential Biomarker for Male Hypogonadism.
     Urology. 2024 Oct 18:S0090-4295(24)00865-3. doi: 10.1016/j.urology.2024.
     PubMed     Abstract available
     
     
     
111. CHECCUCCI E, Bauckneht M, Cisero E, Volpi G, et al
     PSMA PET-targeted Biopsy for Prostate Cancer Diagnosis: Initial Experience from a Multicenter Cohort.
     Urology. 2024 Oct 17:S0090-4295(24)00909-9. doi: 10.1016/j.urology.2024.
     PubMed     Abstract available
     
     
     
112. KRONSTEDT S, Chiu CB, Wahlstedt E, Cathey J, et al
     Should Military Veterans Be Classified as High Risk for Prostate Cancer Screening? A Systematic Review and Meta-analysis.
     Urology. 2024 Oct 17:S0090-4295(24)00908-7. doi: 10.1016/j.urology.2024.
     PubMed     Abstract available
     
     
     
113. BOWLING GC, Albright JA, Maloney TJ, Chesnut GT, et al
     Reply to Editorial Comment on "Poor Bone Mineral Density is Associated With Increased Risk of Urological Metastases".
     Urology. 2024;192:98-99.
     PubMed    
     
     
     
114. SINGLA N
     Editorial Comment on "Poor Bone Mineral Density is Associated With Increased Risk of Urological Bone Metastases".
     Urology. 2024;192:97-98.
     PubMed    
     
     
     
115. SOPUTRO NA, Olivares R
     Editorial Comment on "Impact of Preoperative LUTS on Health-related Quality of Life Following Radical Prostatectomy: A Propensity Score Matched Longitudinal Study".
     Urology. 2024;192:59-60.
     PubMed    
     
     
     
116. BOWLING GC, Alex Albright J, Maloney TJ, Quinn MS, et al
     Poor Bone Mineral Density Is Associated With Increased Risk of Urological Bone Metastases.
     Urology. 2024;192:88-96.
     PubMed     Abstract available
     
     
     
117. WESTHOFEN T, Feyerabend E, Buchner A, Schlenker B, et al
     Impact of Preoperative LUTS on Health-related Quality of Life Following Radical Prostatectomy: A Propensity Score Matched Longitudinal Study.
     Urology. 2024;192:52-58.
     PubMed     Abstract available
     
     
     September 2024
118. QUALKENBUSH E, Perry AG, Kumar N, Thomas CS, et al
     Virtual reality as an adjunct to traditional patient counseling in patients with newly-diagnosed localized prostate cancer.
     Urology. 2024 Sep 20:S0090-4295(24)00819-7. doi: 10.1016/j.urology.2024.
     PubMed     Abstract available
     
     
     
119. DALL CP
     Editorial comment on "Stereotactic Body Radiation Adoption Impacts Prostate Cancer Treatment Patterns".
     Urology. 2024 Sep 16:S0090-4295(24)00814-8. doi: 10.1016/j.urology.2024.
     PubMed    
     
     
     
120. BULUSU A, Ferrante S, Wu RC, Qi J, et al
     Reply to Editorial Comment on "Current Perceptions, Practice Patterns, and Barriers to Adoption of Transperineal Prostate Biopsy Under Local Anesthesia".
     Urology. 2024;191:20-21.
     PubMed    
     
     
     
121. DALL CP, Liu X, Faraj KS, Srivastava A, et al
     Teaching Hospitals and Textbook Outcomes After Major Urologic Cancer Surgery.
     Urology. 2024;191:64-70.
     PubMed     Abstract available
     
     
     
122. LIU AQ, Chiu PK
     Editorial Comment on Article "Current Perceptions, Practice Patterns, and Barriers to Adoption of Transperineal Prostate Biopsy Under Local Anesthesia".
     Urology. 2024;191:19-20.
     PubMed    
     
     
     
123. BULUSU A, Ferrante S, Wu RC, Qi J, et al
     Current Perceptions, Practice Patterns, and Barriers to Adoption of Transperineal Prostate Biopsy Under Local Anesthesia.
     Urology. 2024;191:12-18.
     PubMed     Abstract available
     
     
     August 2024
124. CHEN L, Fu Z, Dong Q, Zheng F, et al
     Machine Learning-Based Nomograms for Predicting Clinical Stages of Initial Prostate Cancer: A Multicenter Retrospective Study.
     Urology. 2024 Aug 14:S0090-4295(24)00656-3. doi: 10.1016/j.urology.2024.
     PubMed     Abstract available
     
     
     
125. STENCEL MG, Wu S, Danielle SR, Yabes JG, et al
     Stereotactic Body Radiation Adoption Impacts Prostate Cancer Treatment Patterns.
     Urology. 2024 Aug 9:S0090-4295(24)00639-3. doi: 10.1016/j.urology.2024.
     PubMed     Abstract available
     
     
     
126. LI J, Cohen RJ
     Impact of Autonomic Nerve Invasion on Biochemical Recurrence for Intermediate Risk T3a Prostate Cancer With Negative Surgical Margins After Radical Prostatectomy.
     Urology. 2024 Aug 8:S0090-4295(24)00643-5. doi: 10.1016/j.urology.2024.
     PubMed     Abstract available
     
     
     July 2024
127. SKOKAN AJ
     Editorial Comment on "Recovery of Social Continence and Sexual Function in Men With High-risk Prostate Cancer After Radical Prostatectomy: Results From a Statewide Collaborative.".
     Urology. 2024 Jul 27:S0090-4295(24)00603-4. doi: 10.1016/j.urology.2024.
     PubMed    
     
     
     
128. WOODLE T, Quinn G, Laviana AA
     Editorial Comment on "Recovery of Social Continence and Sexual Function in Men With High-risk Prostate Cancer After Radical Prostatectomy: Results From a Statewide Collaborative.".
     Urology. 2024 Jul 27:S0090-4295(24)00624-1. doi: 10.1016/j.urology.2024.
     PubMed    
     
     
     
129. MILLOT J, Arenas-Gallo C, Shoag JE
     Reply to Letter to the Editor on "Major Complications and Adverse Events Related to use of SpaceOAR Hydrogel for Prostate Cancer Radiotherapy".
     Urology. 2024 Jul 11:S0090-4295(24)00561-2. doi: 10.1016/j.urology.2024.
     PubMed    
     
     
     
130. PETTENUZZO G, Ditonno F, Cannoletta D, Morgantini L, et al
     Single Port Radical Prostatectomy as a Viable Option for Highly Complex Patients: A Single Center Experience.
     Urology. 2024;189:55-63.
     PubMed     Abstract available
     
     
     
131. APONTE-COLON DA, Creviston A, Abern M, Routh JC, et al
     Radiation-induced Sarcoma of the Prostate After Treatment for Rhabdomyosarcoma.
     Urology. 2024;189:e1-e3.
     PubMed     Abstract available
     
     
     June 2024
132. TRINER D, Johnson K, Meah S, Daignault-Newton S, et al
     RECOVERY OF SOCIAL CONTINENCE AND SEXUAL FUNCTION IN MEN WITH HIGH-RISK PROSTATE CANCER AFTER RADICAL PROSTATECTOMY: RESULTS FROM A STATEWIDE COLLABORATIVE.
     Urology. 2024 Jun 25:S0090-4295(24)00464-3. doi: 10.1016/j.urology.2024.
     PubMed     Abstract available
     
     
     
133. BOLOGNA E, Autorino R
     Reply to Editorial Comment on "Incidence and Management of Radiation Cystitis After Pelvic Radiotherapy for Prostate Cancer: Analysis from a National Database".
     Urology. 2024 Jun 20:S0090-4295(24)00475-8. doi: 10.1016/j.urology.2024.
     PubMed    
     
     
     
134. SANTORO G, Lombardo R, De Nunzio C
     Letter to the Editor on "Major Complications and Adverse Events Related to Use of SpaceOAR Hydrogel for Prostate Cancer Radiotherapy".
     Urology. 2024 Jun 20:S0090-4295(24)00480-1. doi: 10.1016/j.urology.2024.
     PubMed    
     
     
     
135. GARCIA ROJO E
     Reply to Letter to the Editor on "Comparison in Detection Rate of Clinically Significant Prostate Cancer Between Microultrasound-guided Prostate Biopsy (ExactVu) and Multiparametric Resonance Imaging-guided Prostate Biopsy (Koelis System)".
     Urology. 2024 Jun 12:S0090-4295(24)00459-X. doi: 10.1016/j.urology.2024.
     PubMed    
     
     
     
136. HOWLAND R, Srivastava A
     Editorial Comment on "Incidence and Management of Radiation Cystitis After Pelvic Radiotherapy for Prostate Cancer: Analysis from a National Database.".
     Urology. 2024 Jun 1:S0090-4295(24)00421-7. doi: 10.1016/j.urology.2024.
     PubMed    
     
     
     
137. RAMOS-CARPINTEYRO R, Kaouk J
     Reply to Letter to the Editor on "Predictors of Early Continence After Single-port Transvesical Robot-assisted Radical Prostatectomy".
     Urology. 2024;188:169.
     PubMed    
     
     
     
138. FRANCO A, Guercio A, Lombardo R, De Nunzio C, et al
     Letter to the Editor on "Predictors of Early Continence after Single-Port Transvesical Robot-Assisted Radical Prostatectomy".
     Urology. 2024;188:167-168.
     PubMed    
     
     
     
139. GHAMANDE SS, Cline JK, Sayyid RK, Klaassen Z, et al
     Advancing Precision Oncology With Artificial Intelligence: Ushering in the ArteraAI Prostate Test.
     Urology. 2024;188:20-23.
     PubMed    
     
     
     May 2024
140. JIN T, An J, Wu W, Zhou F, et al
     Development and validation of a machine learning model for bone metastasis in prostate cancer: Based on inflammatory and nutritional indicators.
     Urology. 2024 May 31:S0090-4295(24)00415-1. doi: 10.1016/j.urology.2024.
     PubMed     Abstract available
     
     
     
141. VAN VELTHOVEN R, Diamand R, Mozer P, Barry de Longchamp N, et al
     Letter to the Editor on "Comparison in Detection Rate of Clinically Significant Prostate Cancer Between Microultrasound-guided Prostate Biopsy (ExactVu) and Multiparametric Resonance Imaging-guided Prostate Biopsy (Koelis System)".
     Urology. 2024 May 8:S0090-4295(24)00346-7. doi: 10.1016/j.urology.2024.
     PubMed    
     
     
     
142. MILLOT J, Arenas-Gallo C, Silver E, Goldman M, et al
     Reply by Authors - Major Complications and Adverse Events Related to use of SpaceOAR Hydrogel for Prostate Cancer Radiotherapy.
     Urology. 2024 May 6:S0090-4295(24)00345-5. doi: 10.1016/j.urology.2024.
     PubMed    
     
     
     
143. STANIORSKI CJ, Malek MM, Waltz PK, Reyes-Mugica M, et al
     Pelvic Neuroblastoma of the Pediatric Prostate.
     Urology. 2024;187:82-85.
     PubMed     Abstract available
     
     
     April 2024
144. BOLOGNA E, Licari LC, Franco A, Ditonno F, et al
     Incidence and Management of Radiation Cystitis After Pelvic Radiotherapy for Prostate Cancer: Analysis from a National Database.
     Urology. 2024 Apr 29:S0090-4295(24)00308-X. doi: 10.1016/j.urology.2024.
     PubMed     Abstract available
     
     
     
145. VAN DER EECKEN H, Vansevenant B, Devos G, Roussel E, et al
     Nutritional supplement with fermented soy in men with an elevated risk of prostate cancer and negative prostate biopsies: General and oncological results from the prospective PRAECAP trial.
     Urology. 2024 Apr 24:S0090-4295(24)00300-5. doi: 10.1016/j.urology.2024.
     PubMed     Abstract available
     
     
     
146. KLAASSEN Z, Kyle Cline J, Sayyid RK
     Editorial Comment on "Major Complications and Adverse Events Related to use of SpaceOAR Hydrogel for Prostate Cancer Radiotherapy".
     Urology. 2024 Apr 20:S0090-4295(24)00274-7. doi: 10.1016/j.urology.2024.
     PubMed    
     
     
     March 2024
147. MILLOT J, Arenas-Gallo C, Silver E, Goldman M, et al
     Major Complications and Adverse Events Related to Use of SpaceOAR Hydrogel for Prostate Cancer Radiotherapy.
     Urology. 2024 Mar 6:S0090-4295(24)00142-0. doi: 10.1016/j.urology.2023.
     PubMed     Abstract available
     
     
     
148. SAWYER MD, Kim FJ, Wiesen B, Lloyd GL, et al
     Novel Prostate Biopsy Technique Using Imaging Fusion in a Patient With Absent Rectum.
     Urology. 2024;185:124-130.
     PubMed     Abstract available
     
     
     
149. TOURINHO-BARBOSA R, Sanchez-Salas R, Sivaraman A, Borges RC, et al
     Urinary Symptoms Change and Quality of Life After Robotic Radical Prostatectomy: A Secondary Analysis of a Randomized Controlled Trial.
     Urology. 2024;185:73-79.
     PubMed     Abstract available
     
     
     February 2024
150. SHAH MS, Lallas CD
     Editorial Commentary on Improving Racial Disparities in Prostate Cancer.
     Urology. 2024 Feb 29:S0090-4295(24)00123-7. doi: 10.1016/j.urology.2024.
     PubMed    
     
     
     
151. FROEHNER M, Gorner M, Merkle L, Kopka K, et al
     (18)Fluorine prostate-specific membrane antigen 1007 positron emission tomography for high-risk prostate cancer.
     Urology. 2024 Feb 27:S0090-4295(24)00131-6. doi: 10.1016/j.urology.2024.
     PubMed    
     
     
     
152. KHAN HM
     Editorial Commentary on Improving Racial Disparities in Prostate Cancer.
     Urology. 2024 Feb 21:S0090-4295(24)00095-5. doi: 10.1016/j.urology.2024.
     PubMed    
     
     
     
153. MANDEL AL, Simhal RK, Shah YB, Wang KR, et al
     Racial disparities in diagnosis and treatment of depression Associated with androgen deprivation therapy for prostate cancer.
     Urology. 2024 Feb 21:S0090-4295(24)00094-3. doi: 10.1016/j.urology.2024.
     PubMed     Abstract available
     
     
     
154. PASSARELLI R, Srivastava A
     Editorial Comment: Prostate Cancer Detection Rate of Transperineal Prostate Biopsy: Cognitive Versus Software Fusion, A Multicenter Analysis.
     Urology. 2024 Feb 20:S0090-4295(24)00091-8. doi: 10.1016/j.urology.2024.
     PubMed    
     
     
     
155. HUNG M, Ross A, Li EV, Pavlovich CP, et al
     Prostate Cancer Detection Rate of Transperineal Prostate Biopsy: Cognitive Versus Software Fusion, A Multicenter Analysis.
     Urology. 2024 Feb 20:S0090-4295(24)00093-1. doi: 10.1016/j.urology.2023.
     PubMed     Abstract available
     
     
     
156. HUNG M, Hu JC
     Author Response: Prostate Cancer Detection Rate of Transperineal Prostate Biopsy: Cognitive Versus Software Fusion, A Multicenter Analysis.
     Urology. 2024 Feb 7:S0090-4295(24)00003-7. doi: 10.1016/j.urology.2024.
     PubMed    
     
     
     
157. ALBERS P, Bennett J, Evans M, Martin ES, et al
     Value of Incremental Biopsy Cores for Microultrasound Targeted Prostate Biopsies.
     Urology. 2024;184:142-148.
     PubMed     Abstract available
     
     
     January 2024
158. LANGBEIN BJ, Berk B, Bay C, Tuncali K, et al
     A Phase II Prospective Blinded Trial of MRI and In-Bore Biopsy in Active Surveillance for Prostate Cancer.
     Urology. 2024 Jan 11:S0090-4295(23)01122-6. doi: 10.1016/j.urology.2023.
     PubMed     Abstract available
     
     
     
159. GARCIA ROJO E, Garcia Gomez B, Sopena Sutil R, Vallejo Arzayus D, et al
     Comparison in Detection Rate of Clinically Significant Prostate Cancer Between Microultrasound-guided Prostate Biopsy (ExactVu) and Multiparametric Resonance Imaging-guided Prostate Biopsy (Koelis System).
     Urology. 2024;183:163-169.
     PubMed     Abstract available
     
     
     
160. NITHIPALAN V, Holler T, Schuler N, Shepard L, et al
     Evaluation of Mixed Reality Technologies for Remote Feedback and Guidance During Transrectal Ultrasound Biopsy Simulation: A Prospective, Randomized, Crossover Study.
     Urology. 2024;183:25-31.
     PubMed     Abstract available
     
     
     December 2023
161. GUPTA N, Zebib L, Wittmann D, Nelson CJ, et al
     Unmet sexual health resource needs and preferences for interventions to address these needs among female partners of patients with prostate cancer.
     Urology. 2023 Dec 29:S0090-4295(23)01109-3. doi: 10.1016/j.urology.2023.
     PubMed     Abstract available
     
     
     
162. DIRK K, Rourke K
     Health-Related Quality of Life in Patients with Urethral Stenosis after Radiation Treatment for Prostate Cancer.
     Urology. 2023 Dec 29:S0090-4295(23)01113-5. doi: 10.1016/j.urology.2023.
     PubMed     Abstract available
     
     
     
163. SAKAI A, Borza T, Antar A, Richmond E, et al
     Incidental prostate cancer diagnosis is common after holmium laser enucleation of the prostate.
     Urology. 2023 Dec 1:S0090-4295(23)01037-3. doi: 10.1016/j.urology.2023.
     PubMed     Abstract available
     
     
     
164. HIRST N, McBride KE, Thanigasalam R, Leslie S, et al
     Impact of Preoperative Mental Health on Surgical Outcomes Following Robotic-assisted Radical Prostatectomy.
     Urology. 2023;182:136-142.
     PubMed     Abstract available
     
     
     
165. BUSBY D, Rich JM, Grauer R, Kaufmann B, et al
     Biopsy and Erectile Functional Outcomes of Partial Prostate Ablation: A Systematic Review and Meta-analysis of Prospective Studies.
     Urology. 2023;182:14-26.
     PubMed     Abstract available
     
     
     
166. TAYLOR Z, Snow Z, Musallam S, Thomas B, et al
     Is Urethral Catheterization Necessary in Retzius-sparing Robot-assisted Radical Prostatectomy?
     Urology. 2023;182:133-135.
     PubMed     Abstract available
     
     
     
167. MYRGA JM, Erpenbeck SP, Watts A, Stencel MG, et al
     Patient Reported Outcomes of Transperineal Prostate Biopsy With Tumescent Local Anesthesia.
     Urology. 2023;182:33-39.
     PubMed     Abstract available
     
     
     
168. QUINN A, Klein R, Gochenaur L, Chun B, et al
     Transcorporal Artificial Urinary Sphincter Technique Video.
     Urology. 2023;182:e264-e265.
     PubMed     Abstract available
     
     
     
169. SCHILLER E, Joshi P, El-Ali A, Brenseke W, et al
     In-utero Diagnosis of Prostatic Embryonal Rhabdomyosarcoma.
     Urology. 2023;182:e253-e256.
     PubMed     Abstract available
     
     
     
170. HWANG A, Watson M, Talluri S, Okafor H, et al
     A Novel Perivesical Fat Rotational Flap as an Alternative to Omental Interposition in Challenging Urological Reconstruction.
     Urology. 2023;182:e262-e263.
     PubMed     Abstract available
     
     
     November 2023
171. MYERS JB, Hernandez BS, McCormick B, Ramsay J, et al
     Comparison of Urinary Diversion in Patients with Prostatic Fistula to Those with Localized Radiation Injury after Radiotherapy for the Treatment of Prostate Cancer.
     Urology. 2023 Nov 29:S0090-4295(23)01029-4. doi: 10.1016/j.urology.2023.
     PubMed     Abstract available
     
     
     
172. STENSLAND KD, Caram ME, Herr DJ, Burns JA, et al
     National long-term survival estimates after radical prostatectomy for prostate cancer.
     Urology. 2023 Nov 9:S0090-4295(23)00987-1. doi: 10.1016/j.urology.2023.
     PubMed     Abstract available
     
     
     
173. GERETA S, Hung M, Alexanderani MK, Robinson BD, et al
     Evaluating the Learning Curve for In-office Freehand Cognitive Fusion Transperineal Prostate Biopsy.
     Urology. 2023;181:31-37.
     PubMed     Abstract available
     
     
     
174. ARCEO-OLAIZ R, Smith EA, Stokes C, Eaton BR, et al
     Use of Perirectal Hyaluronic Acid Spacer Prior to Radiotherapy in a Pediatric Patient With Bladder Rhabdomyosarcoma: A Case Report.
     Urology. 2023;181:136-140.
     PubMed     Abstract available
     
     
     
175. ENDERS JJ, Pinto PA, Xu S, Gomella P, et al
     A Novel Magnetic Resonance Imaging/Ultrasound Fusion Prostate Biopsy Technique Using Transperineal Ultrasound: An Initial Experience.
     Urology. 2023;181:76-83.
     PubMed     Abstract available
     
     
     October 2023
176. HEBERT K, Bruno A, Matta R, Horns J, et al
     Impact of Prostate Cancer Related Genitourinary Radiation Injury on Mental Health Diagnosis and Treatment: Assessment of 55,425 Men.
     Urology. 2023 Oct 12:S0090-4295(23)00866-X. doi: 10.1016/j.urology.2023.
     PubMed     Abstract available
     
     
     
177. REZAEE ME, Gardner U, Alshak MN, Greco SC, et al
     Title: Effect of Transperineal versus Transrectal Prostate Biopsy on the Quality of Hydrogel Spacer Placement in Men prior to Radiation Therapy for Prostate Cancer.
     Urology. 2023 Oct 5:S0090-4295(23)00858-0. doi: 10.1016/j.urology.2023.
     PubMed     Abstract available
     
     
     
178. BHANJI Y, Mamawala M, de la Calle CM, Landis P, et al
     Prostate Cancer Radiological Estimation of Change in Sequential Evaluation (PRECISE) Magnetic Resonance Imaging Scoring to Predict Clinical Outcomes in Active Surveillance for Grade Group 1 Prostate Cancer.
     Urology. 2023;180:194-199.
     PubMed     Abstract available
     
     
     
179. SOPUTRO NA, Ferguson EL, Ramos-Carpinteyro R, Chavali JS, et al
     The Transition Toward Opioid-sparing Outpatient Radical Prostatectomy: A Single Institution Experience With Three Contemporary Robotic Approaches.
     Urology. 2023;180:140-150.
     PubMed     Abstract available
     
     
     
180. SOPUTRO NA, Ferguson EL, Ramos-Carpinteyro R, Sauer Calvo R, et al
     Low Risk of Postoperative Hernia Following Single-port Robot-assisted Radical Prostatectomy: A Report From the Single-port Advanced Research Consortium (SPARC).
     Urology. 2023;180:151-159.
     PubMed     Abstract available
     
     
     
181. BRAUN AE 3RD, Washington SL, Cowan JE, Hampson LA, et al
     Impact of Stress Urinary Incontinence After Radical Prostatectomy on Time to Intervention, Quality of Life and Work Status.
     Urology. 2023;180:242-248.
     PubMed     Abstract available
     
     
     
182. COSKUN B, Ocakoglu G, Yetemen M, Kaygisiz O, et al
     Can ChatGPT, an Artificial Intelligence Language Model, Provide Accurate and High-quality Patient Information on Prostate Cancer?
     Urology. 2023;180:35-58.
     PubMed     Abstract available
     
     
     September 2023
183. MADHAVAN K, Jena R, Viswas MR, Kaushal D, et al
     Does Radical Local Treatment in oligometastatic Prostate Cancer improve Overall Survival- A systematic review and meta-analysis.
     Urology. 2023 Sep 27:S0090-4295(23)00833-6. doi: 10.1016/j.urology.2023.
     PubMed     Abstract available
     
     
     
184. BRAUN AE, Cowan JE, Hampson LA, Broering JM, et al
     Association between common urologic medications and onset of Alzheimer's disease and related dementias in men with prostate cancer managed by different primary treatment modalities.
     Urology. 2023 Sep 7:S0090-4295(23)00740-9. doi: 10.1016/j.urology.2023.
     PubMed     Abstract available
     
     
     
185. ODERDA M, Grimaldi S, Rovera G, Delsedime L, et al
     Robot-assisted PSMA-radioguided surgery to assess surgical margins and nodal metastases in prostate cancer patients: report on three cases using an intraoperative PET-CT specimen imager.
     Urology. 2023 Sep 3:S0090-4295(23)00730-6. doi: 10.1016/j.urology.2023.
     PubMed     Abstract available
     
     
     
186. XU AJ, Panken EJ, Gonzales-Alabastro CD, Zhang H, et al
     Urologists and Lesbian, Gay, Bisexual, Transgender, or Queer Patients: A Survey-based Study of the Practice Patterns, Attitudes, and Knowledge Base of Urologists Toward Their Lesbian, Gay, Bisexual, Transgender, or Queer Patients.
     Urology. 2023;179:71-79.
     PubMed     Abstract available
     
     
     July 2023
187. PAULA DOMINO M, Vertosick EA, Vickers AJ, Eastham JA, et al
     The association between low preoperative serum testosterone and post radical prostatectomy urinary function.
     Urology. 2023 Jul 27:S0090-4295(23)00654-4. doi: 10.1016/j.urology.2023.
     PubMed     Abstract available
     
     
     
188. VALLI J, Haapiainen H, Murtola TJ, Huhtala H, et al
     Visual Analogue Scale and Expanded Prostate Cancer Index Composite-26 in the Evaluation of Urinary Continence Recovery After Three-Dimensional Laparoscopic Radical Prostatectomy, a Single-Center Prospective Registered Study.
     Urology. 2023;177:103-108.
     PubMed     Abstract available
     
     
     
189. CRISOSTOMO-WYNNE T, Lee K, Speir R
     Robot-assisted Laparoscopic Prostatectomy After SpaceOAR Placement.
     Urology. 2023;177:228-229.
     PubMed     Abstract available
     
     
     
190. DERIGS F, Kowalewski KF, Hartung FO, Waldbillig F, et al
     A Matched-pair Analysis Comparing Systematic Prostate Biopsy by Conventional Transrectal Ultrasound-guidance Versus Software-based Predefined 3D-Guidance.
     Urology. 2023;177:128-133.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum